(Q30080004)

English

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

scientific article published on 26 November 2005

In more languages

Statements

scholarly article

0 references

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

type 2 diabetes

0 references

circulatory system

1 reference

based on heuristic

inferred from title

19

object named as

Laakso M

1 reference

28 May 2017

Paul P. Glasziou

10

object named as

Glasziou P

1 reference

28 May 2017

Marja-Riitta Taskinen

6

object named as

Taskinen MR

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

author name string

Keech A

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Simes RJ

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Barter P

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Best J

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Scott R

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Forder P

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Pillai A

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Davis T

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Drury P

11

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Kesäniemi YA

12

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Sullivan D

13

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Hunt D

14

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Colman P

15

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

d'Emden M

16

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Whiting M

17

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Ehnholm C

18

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

publication date

26 November 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

366

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

1849-61

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

9500

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetic dyslipidaemia: from basic research to clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamic balanced randomization for clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of different antilipidemic agents and diets on mortality: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fenofibrate increases creatininemia by increasing metabolic production of creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

WHO clofibrate/cholesterol trial: clarifications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967667-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)67667-2

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16310551

28 May 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30080004&oldid=1551323286"